As filed with the Securities and Exchange Commission on March 31,
2009 Registration No. 333-128399
----------------------------------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SINOBIOMED INC.
Delaware 2834 20-1945139 82934C 10 2
(State or other (Primary Standard (I.R.S. Employer CUSIP Number
jurisdiction Industrial Identification
of incorporation Classification Number)
or organization) Number)
Lane 4705, No. 58 North Yang Gao Rd.
Pudong New Area Shanghai, China 201206
Tel: 011-86-21-58546923
(executive office)
With copy to:
Devlin Jensen
Barristers & Solicitors
Attn: Mike Shannon
Suite 2550 - 555 W. Hastings St.
Vancouver, British Columbia, Canada, V6B 4N5
Tel: (604) 684-2550 Fax: (604) 684-0916
(Agent for Service)
(Check one): X Form 10-K |_| Form 20-F |_| Form 11-K |_| Form 10-Q
|_| Form 10-D |_| Form N-SAR |_| Form N-CSR
For Period Ended: December 31, 2008
|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-K
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended:
PART I -- REGISTRANT INFORMATION
Sinobiomed Inc.
Lane 4705, No. 58 North Yang Gao Rd.
Pudong New Area Shanghai
China 201206
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b- 25(b), the following
should be completed. (Check box if appropriate)
[x]
(a) The reason described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
effort or expense
(b) The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, Form 11-K,
Form NSAR or Form N-CSR, or portion thereof, will be
filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report
of transition report on Form 10-Q or subject
distribution report on Form 10-D, or portion thereof,
will be filed on or before the fifth calendar day
following the prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III -- NARRATIVE
The Registrant's recent activities have delayed the preparation and
review of its Annual Report on Form 10-K. The Registrant represents that the
Form 10-K will be filed by no later than the 15th day following the date on
which the Form 10-K was due.
PART IV -- OTHER INFORMATION
The name and telephone number of person to contact in regard to this
notification is:
Ka Yu 011-86-21 58546923
- -------------------------------------------------------------------
Name Area Code Telephone Number
(1) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months (or for such shorter) period that the
registrant was required to file such reports) been filed? If answer is no,
identify reports:
|X| Yes |_| No
(2) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
|_| Yes |X| No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Sinobiomed Inc.
- --------------------------------------------------------------------------------
Name of Registrant as Specified in Charter
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date March 30, 2009 By /s/ Ka Yu
--------------------------------
Ka Yu
Secretary and Director